Dr. Adam Striker and Dr. Aaron Primm, editor for Summaries of Emerging Evidence (SEE), discuss recent studies included in the 40B issue of SEE that add to our understanding of ketamine. Learn how ketamine compares to electroconvulsive therapy (ECT) for the treatment of chronic depression and how intranasal ketamine might be used to treat refractory chronic migraines (https://www.asahq.org/see). Recorded July 2024.